683 Capital Management, LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 161 filers reported holding FATE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.

Quarter-by-quarter ownership
683 Capital Management, LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$11,366,000
+26.4%
125,000
-44.4%
0.54%
-18.4%
Q3 2020$8,993,000
+16.5%
225,0000.0%0.66%
+6.6%
Q2 2020$7,720,000
-22.8%
225,000
-50.0%
0.62%
+5.1%
Q1 2020$9,994,000
+127.0%
450,000
+100.0%
0.59%
+16.7%
Q4 2019$4,403,000
+26.0%
225,0000.0%0.50%
+29.6%
Q3 2019$3,494,000
-42.6%
225,000
-25.0%
0.39%
-29.8%
Q2 2019$6,090,000
-12.2%
300,000
-24.1%
0.55%
-11.9%
Q1 2019$6,940,000
+33.6%
395,000
-2.5%
0.63%
+99.7%
Q4 2018$5,196,000
-50.9%
405,000
-37.7%
0.32%
-54.1%
Q3 2018$10,585,000
+25.5%
649,800
-12.7%
0.69%
+20.5%
Q2 2018$8,437,000
-13.0%
744,011
-25.1%
0.57%
-33.5%
Q1 2018$9,699,000
+85.9%
993,711
+16.4%
0.86%
+94.8%
Q4 2017$5,217,000
+94.1%
853,800
+25.8%
0.44%
+56.0%
Q3 2017$2,688,000
+41.0%
678,800
+15.4%
0.28%
+0.4%
Q2 2017$1,906,000
-10.9%
588,237
+25.2%
0.28%
-15.4%
Q1 2017$2,139,000470,0000.33%
Other shareholders
FATE THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$131,006,00024.77%
Redmile Group, LLC 12,957,222$502,351,00015.68%
Grosvenor Holdings, L.L.C. 1,037,256$40,214,0007.85%
Casdin Capital, LLC 3,400,000$131,818,0005.91%
Ally Bridge Group (NY) LLC 181,500$7,037,0005.22%
DAFNA Capital Management LLC 500,930$19,421,0005.06%
Deep Track Capital, LP 2,000,000$77,540,0004.97%
Artal Group S.A. 2,000,000$77,540,0003.25%
Tri Locum Partners LP 190,345$7,380,0002.88%
ARK Investment Management 10,988,182$426,012,0001.78%
View complete list of FATE THERAPEUTICS INC shareholders